Here are four things to know:
• The stock was sold at an average price of $45.52, for a total transaction of $360,518.
• Mr. Miles now directly owns 91,688 shares in the company, valued at approximately $4,173,637.
• The company’s stock currently has an average rating of “buy” and an average price target of $52.27.
• NuVasive has a 52-week low of $31.35 and a 52-week high of $51.23.
More articles on devices:
DOJ extends Biomet’s deferred prosecution agreement
Oppenheimer updates Globus Medical price target — 5 key notes
Are Medtronic shares undervalued at $77 per share? 7 things to know
